Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04739358
Title CNS Dose Escalation/Expansion of Tepotinib in MET-driven NSCLC
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Criterium, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Georgetown Lombardi Comprehensive Cancer Center Washington District of Columbia 20007 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
University of Washington Seattle Washington 98195 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field